CapMan Oyj Series B
CapMan Oyj is a leading Nordic private assets management and investment firm with an active approach to value creation and private equity and venture capital firm specializing in growth capital investments, industry consolidation, special situations, turnaround, recapitalization, middle market buyouts, credit and mezzanine financing in unquoted companies, investments in value-add and income focus… Read more
CapMan Oyj Series B (0E1L) - Net Assets
Latest net assets as of December 2025: €194.40 Million EUR
Based on the latest financial reports, CapMan Oyj Series B (0E1L) has net assets worth €194.40 Million EUR as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€337.65 Million) and total liabilities (€143.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €194.40 Million |
| % of Total Assets | 57.57% |
| Annual Growth Rate | 5.79% |
| 5-Year Change | 52.6% |
| 10-Year Change | 35.96% |
| Growth Volatility | 30.21 |
CapMan Oyj Series B - Net Assets Trend (2002–2025)
This chart illustrates how CapMan Oyj Series B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CapMan Oyj Series B (2002–2025)
The table below shows the annual net assets of CapMan Oyj Series B from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €194.40 Million | -4.03% |
| 2024-12-31 | €202.57 Million | +75.95% |
| 2023-12-31 | €115.12 Million | -19.01% |
| 2022-12-31 | €142.14 Million | +11.58% |
| 2021-12-31 | €127.39 Million | +12.47% |
| 2020-12-31 | €113.27 Million | -12.56% |
| 2019-12-31 | €129.53 Million | +7.08% |
| 2018-12-31 | €120.97 Million | -4.52% |
| 2017-12-31 | €126.69 Million | -11.39% |
| 2016-12-31 | €142.98 Million | +119.34% |
| 2015-12-31 | €65.19 Million | -0.58% |
| 2014-12-31 | €65.57 Million | +1.09% |
| 2013-12-31 | €64.86 Million | -18.05% |
| 2012-12-31 | €79.15 Million | -10.30% |
| 2011-12-31 | €88.24 Million | -3.03% |
| 2010-12-31 | €91.00 Million | +16.36% |
| 2009-12-31 | €78.20 Million | +13.10% |
| 2008-12-31 | €69.15 Million | +2.38% |
| 2007-12-31 | €67.54 Million | +18.61% |
| 2006-12-31 | €56.95 Million | +16.00% |
| 2005-12-31 | €49.09 Million | +2.08% |
| 2004-12-31 | €48.09 Million | +6.09% |
| 2003-12-31 | €45.33 Million | -14.97% |
| 2002-12-31 | €53.31 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CapMan Oyj Series B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 559.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €93.33 Million | 49.62% |
| Common Stock | €35.20 Million | 18.71% |
| Other Comprehensive Income | €-518.00K | -0.28% |
| Other Components | €60.08 Million | 31.94% |
| Total Equity | €188.09 Million | 100.00% |
CapMan Oyj Series B Competitors by Market Cap
The table below lists competitors of CapMan Oyj Series B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dutch Lady Milk Industries Bhd
KLSE:3026
|
$182.02 Million |
|
Linhai Co Ltd
SHG:600099
|
$182.06 Million |
|
Global Indemnity Group, LLC Class A Common Stock
NASDAQ:GBLI
|
$182.12 Million |
|
Humacyte Inc
NASDAQ:HUMA
|
$182.16 Million |
|
Halla Holdings Corp
KO:060980
|
$181.82 Million |
|
LUOYANG GLASS CO. H YC 1
F:LUG
|
$181.80 Million |
|
Panda Dairy Corp
SHE:300898
|
$181.77 Million |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
$181.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CapMan Oyj Series B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 198,793,000 to 188,090,000, a change of -10,703,000 (-5.4%).
- Net income of 13,182,000 contributed positively to equity growth.
- Dividend payments of 27,490,000 reduced retained earnings.
- Other comprehensive income decreased equity by 518,000.
- Other factors increased equity by 4,123,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €13.18 Million | +7.01% |
| Dividends Paid | €27.49 Million | -14.62% |
| Other Comprehensive Income | €-518.00K | -0.28% |
| Other Changes | €4.12 Million | +2.19% |
| Total Change | €- | -5.38% |
Book Value vs Market Value Analysis
This analysis compares CapMan Oyj Series B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.58x to 0.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €0.71 | €1.82 | x |
| 2003-12-31 | €0.61 | €1.82 | x |
| 2004-12-31 | €0.64 | €1.82 | x |
| 2005-12-31 | €0.65 | €1.82 | x |
| 2006-12-31 | €0.70 | €1.82 | x |
| 2007-12-31 | €0.86 | €1.82 | x |
| 2008-12-31 | €0.83 | €1.82 | x |
| 2009-12-31 | €0.89 | €1.82 | x |
| 2010-12-31 | €1.08 | €1.82 | x |
| 2011-12-31 | €1.05 | €1.82 | x |
| 2012-12-31 | €0.94 | €1.82 | x |
| 2013-12-31 | €0.77 | €1.82 | x |
| 2014-12-31 | €0.76 | €1.82 | x |
| 2015-12-31 | €0.74 | €1.82 | x |
| 2016-12-31 | €1.57 | €1.82 | x |
| 2017-12-31 | €0.86 | €1.82 | x |
| 2018-12-31 | €0.81 | €1.82 | x |
| 2019-12-31 | €0.82 | €1.82 | x |
| 2020-12-31 | €0.72 | €1.82 | x |
| 2021-12-31 | €0.78 | €1.82 | x |
| 2022-12-31 | €0.88 | €1.82 | x |
| 2023-12-31 | €0.71 | €1.82 | x |
| 2024-12-31 | €1.14 | €1.82 | x |
| 2025-12-31 | €105.61 | €1.82 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CapMan Oyj Series B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.01%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.90%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 1.80x
- Recent ROE (7.01%) is below the historical average (11.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 6.39% | 16.86% | 0.35x | 1.10x | €-1.91 Million |
| 2003 | 2.52% | 6.12% | 0.38x | 1.08x | €-3.39 Million |
| 2004 | 10.31% | 0.00% | 0.00x | 1.12x | €150.77K |
| 2005 | 14.34% | 24.31% | 0.50x | 1.18x | €2.11 Million |
| 2006 | 20.33% | 2027.43% | 0.01x | 1.41x | €5.82 Million |
| 2007 | 35.90% | 1203.33% | 0.02x | 1.74x | €17.48 Million |
| 2008 | -11.69% | -328.76% | 0.02x | 2.00x | €-14.95 Million |
| 2009 | 0.18% | 7.05% | 0.01x | 1.83x | €-7.64 Million |
| 2010 | 19.35% | 823.45% | 0.01x | 1.72x | €8.48 Million |
| 2011 | 12.35% | 33.60% | 0.23x | 1.61x | €2.07 Million |
| 2012 | 3.42% | 9.92% | 0.21x | 1.63x | €-5.21 Million |
| 2013 | 2.25% | 4.90% | 0.27x | 1.70x | €-5.03 Million |
| 2014 | 6.05% | 10.04% | 0.35x | 1.74x | €-2.59 Million |
| 2015 | 9.29% | 19.06% | 0.21x | 2.30x | €-464.50K |
| 2016 | 10.69% | 57.30% | 0.11x | 1.77x | €988.10K |
| 2017 | 12.21% | 44.40% | 0.16x | 1.67x | €2.80 Million |
| 2018 | 6.69% | 23.94% | 0.16x | 1.71x | €-3.99 Million |
| 2019 | 10.96% | 28.51% | 0.23x | 1.70x | €1.22 Million |
| 2020 | 4.57% | 11.96% | 0.20x | 1.94x | €-6.11 Million |
| 2021 | 27.29% | 65.02% | 0.22x | 1.91x | €21.74 Million |
| 2022 | 28.29% | 58.66% | 0.25x | 1.93x | €25.61 Million |
| 2023 | 1.19% | 2.73% | 0.20x | 2.13x | €-9.97 Million |
| 2024 | 34.49% | 119.01% | 0.17x | 1.73x | €48.69 Million |
| 2025 | 7.01% | 20.90% | 0.19x | 1.80x | €-5.63 Million |
Industry Comparison
This section compares CapMan Oyj Series B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CapMan Oyj Series B (0E1L) | €194.40 Million | 6.39% | 0.74x | $181.82 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |